Orthofix International NV‘s preliminary first-quarter revenues and earnings numbers indicate flat sales and a slight dip in the bottom line, compared with the same period last year.
The McKinney, Texas-based orthopedic device manufacturer, which has a presence in Boston, said it expects sales for the three-month period ended March 31 to be around $129 million, compared to $128 million for the same period last year.
But that slight uptick won’t help the bottom line. Orthofix said it expects net earnings per share to be in the $0.14 to $.016 range; during the first quarter of 2008, the company posted net EPS of $0.21 per share.
Orthofix did not release any hard sales figures ahead of its official announcement May 6.
The company has gathered its share of headlines lately. Orthofix fended off a proxy challenge from a New York hedge fund earlier this year and yesterday was named in a second reimbursement fraud complaint dating back to 2005, according to recently unsealed court documents.
Orthofix posted a $228 million loss on $556 million in sales for 2008.